Cargando…

Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease

Background and Aims: Hepatocellular iron accumulation in patients with chronic liver disease has been linked to adverse outcomes. The objective of this study was to identify clinical factors associated with hemosiderosis. Methods: A total of 103 consecutive liver transplant recipients were identifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fierro-Fine, Amelia, Guerin, Leana, Hicsasmaz, Hasan, Brown, Kyle E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562807/ https://www.ncbi.nlm.nih.gov/pubmed/33083244 http://dx.doi.org/10.14218/JCTH.2020.00022

Ejemplares similares

Mirizzi Syndrome in a Cirrhotic Patient After TIPS Resolved by Technetium(99m) Mebrofenin Hepatobiliary Scan
por: Jehangir, Asad, et al.
Publicado: (2016)

A Late Presentation of a Fatal Disease: Juvenile Hemochromatosis
por: Cherfane, Cynthia, et al.
Publicado: (2013)

Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy
por: Frankul, Leana, et al.
Publicado: (2021)

Distinct Iron Deposition Profiles of Liver Zones in Various Models with Iron Homeostasis Disorders
por: Song, Haoyang, et al.
Publicado: (2018)

End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2019)

Iron deposition in autopsied liver specimens from older patients receiving intravenous iron infusion
por: Akatsu, Hiroyasu, et al.
Publicado: (2020)

Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis
por: Koopman, Jacob J E, et al.
Publicado: (2020)

End-stage renal disease after bariatric surgery
por: Crews, Deidra C., et al.
Publicado: (2008)

Aortic elasticity changes in thalassemia due to heart and liver iron deposition
por: Noori, Noor Mohammad, et al.
Publicado: (2023)

Iatrogenic Iron Overload in an End Stage Renal Disease Patient
por: Aldwairi, Majd M., et al.
Publicado: (2020)

Albumin for End-Stage Liver Disease
por: Lee, June Sung
Publicado: (2012)

Iron-Induced Liver Injury: A Critical Reappraisal
por: Bloomer, Steven A., et al.
Publicado: (2019)

Cerebral Iron Deposition in Neurodegeneration
por: Dusek, Petr, et al.
Publicado: (2022)

Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance
por: Liu, Zhuo, et al.
Publicado: (2017)

Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease
por: Gutiérrez, Orlando M.
Publicado: (2021)

Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients
por: Tang, Justin Y., et al.
Publicado: (2018)

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

Chronotropic incompetence in end-stage liver disease
por: Główczyńska, Renata, et al.
Publicado: (2022)

Liver Regeneration and Cell Transplantation for End-Stage Liver Disease
por: Li, Yan, et al.
Publicado: (2021)

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
por: Lau, Tsang, et al.
Publicado: (2013)

Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model
por: Navidi-Shishaone, Mitra, et al.
Publicado: (2014)

Protective role of melatonin in early‐stage and end‐stage liver cirrhosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Quantitative Analysis of Liver Iron Deposition Based on Dual-Energy CT in Thalassemia Patients
por: Xu, Fengming, et al.
Publicado: (2023)

Re: “Protective Role of Silymarin and Deferoxamine against Iron Dextran-Induced Renal Iron Deposition in Male Rats,” and “Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model”
por: Mazaheri, Safoora, et al.
Publicado: (2014)

The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
por: Kim, Kunhee, et al.
Publicado: (2023)

Iron’s fingerprint of deposits—iron speciation as a geochemical marker
por: Niedzielski, Przemysław, et al.
Publicado: (2017)

Cellular Senescence in Livers from Children with End Stage Liver Disease
por: Gutierrez-Reyes, Gabriela, et al.
Publicado: (2010)

High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
por: Sakpal, Sujit Vijay, et al.
Publicado: (2019)

Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation
por: Raza, Muhammad H., et al.
Publicado: (2023)

The Yin and the Yang of Hemostasis in End-Stage Liver Disease
por: Saner, Fuat H., et al.
Publicado: (2023)

Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study
por: Rostoker, Guy, et al.
Publicado: (2018)

Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
por: Tao, Ya-Chao, et al.
Publicado: (2020)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Treatment of anaemia in end-stage renal disease: A double-edged iron sword?
por: Chinnadurai, Rajkumar, et al.
Publicado: (2019)

Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease
por: Raj, Ashok, et al.
Publicado: (2022)

Correction: Cellular Senescence in Livers from Children with End Stage Liver Disease
por: Gutierrez-Reyes, Gabriela, et al.
Publicado: (2010)

DNA methylation profile of liver tissue in end-stage cholestatic liver disease
por: Cheung, Angela C, et al.
Publicado: (2022)

Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial
por: Shakoor, Amarah, et al.
Publicado: (2014)

Brain iron deposits and lifespan cognitive ability
por: del C. Valdés Hernández, Maria, et al.
Publicado: (2015)

Nigral iron deposition in common tremor disorders
por: Homayoon, Nina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ivbo5lgflg8e5ana7qeddlmi0m